Trials / Completed
CompletedNCT04446052
Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia
Phase III Study Priming With rhu_GM-CSF and of Three Induction Regimens in Adult Patients (55 and Over) With Acute Non-Lymphocytic Leukemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 362 (actual)
- Sponsor
- Eastern Cooperative Oncology Group · Network
- Sex
- All
- Age
- 56 Years
- Healthy volunteers
- Not accepted
Summary
Phase III Study of Priming with Granulocyte-Macrophage Colony Stimulating Factor (rhu-GM-CSF) and ofThree Induction Regimens in Adult Patients (Over 55) with Acute Non-Lymphocytic Leukemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GM-CSF priming | |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 1993-05-21
- Primary completion
- 2002-07-10
- Completion
- 2002-07-10
- First posted
- 2020-06-24
- Last updated
- 2023-06-22
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04446052. Inclusion in this directory is not an endorsement.